DRMA has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
DRMA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Cash Receipts from Tax Refunds only applicable to companies reporting Cash Flow from Operations in direct method.
Brittany Bradrick | director | C/O DERMATA THERAPEUTICS, INC., 3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO CA 92130 |
Gerald T Proehl | 10 percent owner, officer: Pres., CEO and Chairman | |
Van Hoose Kyri K. | officer: Chief Financial Officer | C/O TURNING POINT THERAPEUTICS, INC., 10628 SCIENCE CENTER DRIVE, SUITE 200, SAN DIEGO CA 92121 |
Mary Fisher | director | C/O ACORDA THERAPEUTICS, INC., 15 SKYLINE DRIVE, HAWTHORNE NY 10532 |
David F Hale | director | 1042-B NORTH EL CAMINO REAL, SUITE 430, ENCINITAS CA 92024 |
Steven J Mento | director | C/O SANGAMO BIOSCIENCES, INC., 501 CANAL BLVD SUITE A-100, RICHMOND CA 94804 |
Wendell Wierenga | director | C/O CIPHERGEN BIOSYSTEMS INC, 6611 DUMBARTON CIRCLE, FREMONT CA 94555 |
Kathleen D. Scott | director | C/O CONATUS PHARMACEUTICALS INC., 16745 WEST BERNARDO DRIVE, SUITE 200, SAN DIEGO CA 92127 |
Thomas Insley | officer: Chief Financial Officer | SKINMEDICA, INC., 5909 SEA LION PLACE, SUITE H, CARLSBAD CA 92010 |
Bedoya-toro Munera Maria E | officer: Senior VP | 10590 WEST OCEAN AIR DRIVE, SUITE 200, SAN DIEGO CA 92130 |
Andrew Seth Sandler | director | 1301 2ND AVE, SEATTLE WA 98101 |
Christopher J. Nardo | officer: Senior VP, Development | C/O DERMATA THERAPEUTICS, INC., 3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO CA 92130 |
Proehl Investment Ventures Llc | 10 percent owner | C/O DERMATA THERAPEUTICS, INC., 3525 DEL MAR HEIGHTS RD., #332, SAN DIEGO CA 92130 |
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.